XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Number of Common Shares outstanding
Number of treasury shares
Additional paid-in capital
Common Shares held in treasury
Retained earnings
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2021   27,191          
Beginning balance (in shares) at Dec. 31, 2021     1,775        
Beginning balance at Dec. 31, 2021 $ 295,950     $ 232,490 $ (55,264) $ 215,748 $ (97,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (7,675)         (7,675)  
Unrealized gain (loss) on derivatives, net 1,048           1,048
Currency translation adjustments 4,161           4,161
Issuance of Common Shares ( in shares)   161 161        
Repurchased Common Shares for treasury (in shares)   36 36        
Repurchased Common Shares for treasury, net 4,093       4,093    
Share-based compensation, net (3,653)     (3,653)      
Ending balance (in shares) at Mar. 31, 2022   27,316          
Ending balance (in shares) at Mar. 31, 2022     1,650        
Ending balance at Mar. 31, 2022 293,924     228,837 (51,171) 208,073 (91,815)
Beginning balance (in shares) at Dec. 31, 2021   27,191          
Beginning balance (in shares) at Dec. 31, 2021     1,775        
Beginning balance at Dec. 31, 2021 295,950     232,490 (55,264) 215,748 (97,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (15,014)            
Unrealized gain (loss) on derivatives, net [1] 995            
Ending balance (in shares) at Jun. 30, 2022   27,318          
Ending balance (in shares) at Jun. 30, 2022     1,648        
Ending balance at Jun. 30, 2022 272,528     230,455 (51,081) 200,734 (107,580)
Beginning balance (in shares) at Mar. 31, 2022   27,316          
Beginning balance (in shares) at Mar. 31, 2022     1,650        
Beginning balance at Mar. 31, 2022 293,924     228,837 (51,171) 208,073 (91,815)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (7,339)         (7,339)  
Unrealized gain (loss) on derivatives, net (53) [1]           (53)
Currency translation adjustments (15,712)           (15,712)
Issuance of Common Shares ( in shares)   4 4        
Repurchased Common Shares for treasury (in shares)   2 2        
Repurchased Common Shares for treasury, net 90       90    
Share-based compensation, net 1,618     1,618      
Ending balance (in shares) at Jun. 30, 2022   27,318          
Ending balance (in shares) at Jun. 30, 2022     1,648        
Ending balance at Jun. 30, 2022 $ 272,528     230,455 (51,081) 200,734 (107,580)
Beginning balance (in shares) at Dec. 31, 2022 27,341 27,341          
Beginning balance (in shares) at Dec. 31, 2022 1,625   1,625        
Beginning balance at Dec. 31, 2022 $ 280,942     232,758 (50,366) 201,692 (103,142)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (7,386)         (7,386)  
Unrealized gain (loss) on derivatives, net (232)           (232)
Currency translation adjustments 4,072           4,072
Issuance of Common Shares ( in shares)   234 234        
Repurchased Common Shares for treasury (in shares)   62 (62)        
Repurchased Common Shares for treasury, net 5,649       5,649    
Share-based compensation, net (6,802)     (6,802)      
Ending balance (in shares) at Mar. 31, 2023   27,513          
Ending balance (in shares) at Mar. 31, 2023     1,453        
Ending balance at Mar. 31, 2023 $ 276,243     225,956 (44,717) 194,306 (99,302)
Beginning balance (in shares) at Dec. 31, 2022 27,341 27,341          
Beginning balance (in shares) at Dec. 31, 2022 1,625   1,625        
Beginning balance at Dec. 31, 2022 $ 280,942     232,758 (50,366) 201,692 (103,142)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (10,378)            
Unrealized gain (loss) on derivatives, net [1] $ 56            
Ending balance (in shares) at Jun. 30, 2023 27,522 27,522          
Ending balance (in shares) at Jun. 30, 2023 1,444   1,444        
Ending balance at Jun. 30, 2023 $ 277,638     226,713 (44,367) 191,314 (96,022)
Beginning balance (in shares) at Mar. 31, 2023   27,513          
Beginning balance (in shares) at Mar. 31, 2023     1,453        
Beginning balance at Mar. 31, 2023 276,243     225,956 (44,717) 194,306 (99,302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (2,992)         (2,992)  
Unrealized gain (loss) on derivatives, net 288 [1]           288
Currency translation adjustments 2,992           2,992
Issuance of Common Shares ( in shares)   15 15        
Repurchased Common Shares for treasury (in shares)   6 (6)        
Repurchased Common Shares for treasury, net 350       350    
Share-based compensation, net $ 757     757      
Ending balance (in shares) at Jun. 30, 2023 27,522 27,522          
Ending balance (in shares) at Jun. 30, 2023 1,444   1,444        
Ending balance at Jun. 30, 2023 $ 277,638     $ 226,713 $ (44,367) $ 191,314 $ (96,022)
[1] Net of tax expense (benefit) $76 and $(15) for the three months ended June 30, 2023 and 2022, respectively. Net of tax expense of $15 and $264 for the six months ended June 30, 2023 and 2022, respectively.